NGX-4010 for the Treatment of Postherpetic Neuralgia
|Herpes Zoster Neuralgia Pain Peripheral Nervous System Diseases Shingles||Drug: Capsaicin Dermal Patch||Phase 2 Phase 3|
|Study Design:||Allocation: Randomized
Primary Purpose: Treatment
|Official Title:||A Randomized, Double-Blind, Controlled Dose Finding Study of NGX-4010 for the Treatment of Postherpetic Neuralgia|
Participants will be randomly assigned to receive initial treatment according to one of three doses (application durations), and will receive either NGX-4010 patch (high-concentration capsaicin) or matching control (low-concentration capsaicin).
Participants who complete the study evaluations for 12 weeks will have the option of receiving up to 3 additional open-label re-treatments over 1 year.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00061776
Show 28 Study Locations